4 related articles for article (PubMed ID: 38725219)
1. BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatment.
Tseng HY; Alavi S; Gallagher S; McGuire HM; Hersey P; Al Emran A; Tiffen J
Pigment Cell Melanoma Res; 2024 May; ():. PubMed ID: 38725219
[TBL] [Abstract][Full Text] [Related]
2.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
3.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
4.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]